12:00 AM
Nov 19, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Bexsero regulatory update

EMA's CHMP issued a positive opinion recommending approval of Bexsero from Novartis to vaccinate against meningococcal disease caused by Neisseria...

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >